Publications
Damon LE, Wolf JL, Rugo HS, Gold E, Zander AR, Cassidy M, Cecchi G, Cohen N, Irwin D, Tracy M, Ries CA, Linker CA. High-dose chemotherapy (CTM) for breast cancer. Bone marrow transplantation. 2000. PMID: 10967563
May C, Rivella S, Callegari J, Heller G, Gaensler KM, Luzzatto L, Sadelain M. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature. 2000. PMID: 10894546
Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, Deen DF, Shuman MA. Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia (New York, N.Y.). 2000. PMID: 11005565
Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, Deen DF, Shuman MA. Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia (New York, N.Y.). 2000. PMID: 11005565
Bergsland EK, Venook AP. Hepatocellular carcinoma. Current opinion in oncology. 2000. PMID: 10888422
Bergsland EK, Venook AP. Hepatocellular carcinoma. Current opinion in oncology. 2000. PMID: 10888422
Grossfeld GD, Tigrani VS, Nudell D, Roach M, Weinberg VK, Presti JC, Small EJ, Carroll PR. Management of a positive surgical margin after radical prostatectomy: decision analysis. The Journal of urology. 2000. PMID: 10840431
Venook AP, Egorin MJ, Rosner GL, Hollis D, Mani S, Hawkins M, Byrd J, Hohl R, Budman D, Meropol NJ, Ratain MJ. Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000. PMID: 10894879
Small EJ, Lew D, Redman BG, Petrylak DP, Hammond N, Gross HM, Eastham JA, Crawford ED. Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000. PMID: 10893284
Anderlini P, Donato M, Lauppe MJ, Huh YO, Martin TG, Chan KW, Champlin RE, Körbling M. A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors. British journal of haematology. 2000. PMID: 10929027
Vose JM, Colcher D, Gobar L, Bierman PJ, Augustine S, Tempero M, Leichner P, Lynch JC, Goldenberg D, Armitage JO. Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma. Leukemia & lymphoma. 2000. PMID: 10811451
Venook AP, Althaus B, Warren RS. Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer. The New England journal of medicine. 2000. PMID: 10819648
Small EJ, Figlin R, Petrylak D, Vaughn DJ, Sartor O, Horak I, Pincus R, Kremer A, Bowden C. A phase II pilot study of KW-2189 in patients with advanced renal cell carcinoma. Investigational new drugs. 2000. PMID: 10857997
Small EJ, Reese DM. An update on prostate cancer research. Current opinion in oncology. 2000. PMID: 10841200
McGhee EM, Cohen NR, Wolf JL, Ledesma CT, Cotter PD. Monosomy 16 as the sole abnormality in myeloid malignancies. Cancer genetics and cytogenetics. 2000. PMID: 10748300
Hanahan D, Bergers G, Bergsland E. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. The Journal of clinical investigation. 2000. PMID: 10772648
Small EJ, Meyer M, Marshall ME, Reyno LM, Meyers FJ, Natale RB, Lenehan PF, Chen L, Slichenmyer WJ, Eisenberger M. Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2000. PMID: 10735891
Reese DM, Corry M, Small EJ. Infusional floxuridine-based therapy for patients with metastatic renal cell carcinoma. Cancer. 2000. PMID: 10717611
Ladiges W, Morton J, Blakely C, Gale M. Tissue specific expression of PKR protein kinase in aging B6D2F1 mice. Mechanisms of ageing and development. 2000. PMID: 10799709
Venook AP. Regional strategies for managing hepatocellular carcinoma. Oncology (Williston Park, N.Y.). 2000. PMID: 10742963